Italia markets close in 2 hours
FTSE MIB
33.437,83 -269,38 (-0,80%) Dow Jones
39.112,16 -299,05 (-0,76%) Nasdaq
17.717,65 +220,84 (+1,26%) Nikkei 225
39.667,07 +493,92 (+1,26%) Petrolio
80,89 +0,06 (+0,07%) Bitcoin EUR
57.661,04 +295,52 (+0,52%)
Lotus Pharmaceutical Co., Ltd. (1795.TW)
Taiwan - Taiwan Prezzo differito. Valuta in TWD.
Aggiungi a watchlist
Alla chiusura: 01:30PM CST
| Chiusura precedente | 290,00 |
| Aperto | 291,50 |
| Denaro | 310,00 x N/D |
| Domanda | 310,50 x N/D |
| Min-Max giorno | 290,00 - 312,50 |
| Intervallo di 52 settimane | 205,00 - 347,00 |
| Volume | |
| Media Volume | 5.949.018 |
| Capitalizzazione | 82,117B |
| Beta (mensile su 5 anni) | 0,57 |
| Rapporto PE (ttm) | 20,63 |
| EPS (ttm) | 15,05 |
| Prossima data utili | 08 ago 2024 - 12 ago 2024 |
| Rendimento e dividendo (futuro) | 3,46 (1,19%) |
| Data ex dividendo | 05 lug 2023 |
| Stima target 1A | 438,33 |
GlobeNewswireAmarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
Collaboration Broadens Reach of VAZKEPA to Additional Ten Countries Leveraging Lotus’ Established Commercial and Marketing Expertise in the RegionDUBLIN, Ireland and BRIDGEWATER, N.J. and NANTOU, Taiwan, July 31, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) and Lotus Pharmaceuticals (1795:TT; “Lotus”) today announced that the two companies have entered into a long-term exclusive partnership to distribute and commercialize VAZKEPA® (icosapent ethyl) across 10 countries, including
© 2024 Yahoo. Tutti i diritti riservati.